A Study to Understand the Use of Palbociclib in Canadian Patients With Breast Cancer That Has Spread to Other Organs
NCT06003114
·
clinicaltrials.gov ↗
COMPLETED
Status
472
Enrollment
INDUSTRY
Sponsor class
Conditions
Breast Cancer
Interventions
DRUG:
Palbociclib
Sponsor
Pfizer